{"id":"d930","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding D930's specific molecular mechanism. As a phase 3 candidate from Chong Kun Dang Pharmaceutical, it has progressed through early clinical testing, but detailed mechanistic data has not been widely disclosed in accessible pharmaceutical databases or literature.","oneSentence":"D930 is an investigational drug in phase 3 development by Chong Kun Dang Pharmaceutical with an undisclosed mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:24.734Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05207761","phase":"PHASE1","title":"Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2022-01-19","conditions":"Glaucoma","enrollment":32},{"nctId":"NCT03762369","phase":"PHASE3","title":"A Clinical Study to Evaluate the Efficacy and Safety of CKD-351","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2018-12-07","conditions":"Primary Open-angle Glaucoma, Ocular Hypertension","enrollment":384},{"nctId":"NCT03034486","phase":"PHASE1","title":"The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2017-02-17","conditions":"Healthy","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"D930","genericName":"D930","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}